Acquisitions

3 Months Ended

Nov. 30, 2014

Acquisitions [Abstract]

Acquisitions

Note 4.  Acquisitions

The aggregate purchase price of all business and intangible asset acquisitions was $13 million for the three months ended November 30, 2014.  These acquisitions added $10 million to intangible assets, primarily prescription files.  The remaining $3 million in fair values of business acquisitions in the period r5elate to immaterial amounts of tangible assets, less assumed liabilities.  Operating results of the businesses acquired have been included in the Consolidated Condensed Statements of Earnings from their respective acquisition dates forward and were not material.  The Company finalized  its purchase accounting of Kerr Drug in the first quarter of fiscal 2014, which added $42 million to goodwill and $54 million to intangible assets, primarily prescription files and payer contracts and the remaining $74 million allocated to net tangible assets.